Chemoinformaics analysis of alpha-Bisabololbeta-D-fucopyranoside
Molecular Weight | 911.092 | nRot | 9 |
Heavy Atom Molecular Weight | 836.5 | nRig | 49 |
Exact Molecular Weight | 910.493 | nRing | 9 |
Solubility: LogS | -3.848 | nHRing | 5 |
Solubility: LogP | 2.107 | No. of Aliphatic Rings | 9 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 138 | No. of Aliphatic Hetero Cycles | 5 |
No. of Heavy Atom | 64 | No. of Aromatic Carbocycles | 0 |
nHetero | 17 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 74 | No. of Saturated Hetero Cycles | 4 |
No. of Carbon atom | 47 | No. of Saturated Rings | 8 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 17 | No. of Arom Bond | 0 |
nHA | 17 | APOL | 141.467 |
nHD | 7 | BPOL | 90.7293 |
QED | 0.166 |
Synth | 6.636 |
Natural Product Likeliness | 1.706 |
NR-PPAR-gamma | 0.504 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.019 |
Pgp-sub | 0.023 |
HIA | 0.202 |
CACO-2 | -5.845 |
MDCK | 0.000176371 |
BBB | 0.054 |
PPB | 0.589302 |
VDSS | 0.194 |
FU | 0.108848 |
CYP1A2-inh | 0 |
CYP1A2-sub | 0.406 |
CYP2c19-inh | 0.001 |
CYP2c19-sub | 0.344 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.051 |
CYP2d6-inh | 0 |
CYP2d6-sub | 0.16 |
CYP3a4-inh | 0.013 |
CYP3a4-sub | 0.61 |
CL | 17.172 |
T12 | 0.018 |
hERG | 0.454 |
Ames | 0.091 |
ROA | 0.998 |
SkinSen | 0.05 |
Carcinogencity | 0.084 |
EI | 0.003 |
Respiratory | 0.844 |
NR-Aromatase | 0.796 |
Antiviral | Yes |
Prediction | 0.786694 |